Craft

SQZ Biotech

Stock Price

$0.1

2023-09-01

Market Capitalization

$12.8 M

2023-09-01

Revenue

$21.5 M

FY, 2022

SQZ Biotech Summary

Company Summary

Overview
SQZ Biotechnologies is a company that develops cell therapies for patients with cancer and infectious diseases. It uses Cell Squeeze, a method to physically squeeze cells through a microfluidic chip and open the cell membrane for biological material of interest to diffuse into the cell. The company provides technologies for oncology, autoimmune disease treatment, and regenerative medicine applications.
Type
Public
Status
Closed
Founded
2013
HQ
Watertown, MA, US | view all locations
Website
http://sqzbiotech.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Armon Sharei

    Armon Sharei, Chief Executive Officer and Founder

  • Howard Bernstein
  • Larry Knopf
  • Andrew Elnatan

    Andrew Elnatan, VP, Regulatory Affairs

Operating MetricsView all

Pre-Clinical Phase Products

10

Q2, 2020

Phase I Trials Products

1

Q2, 2020

LocationsView all

1 location detected

  • Watertown, MA HQ

    United States

    200 Arsenal Yards Blvd

SQZ Biotech Financials

Summary Financials

Net income (Q3, 2023)
($23.6M)
Cash (Q3, 2023)
$10.2M
EBIT (Q3, 2023)
($23.8M)
Enterprise value
$24.1M

Footer menu